Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.30 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26059540 | 1.00 | KDM4E (0.34) | KDM4EATML3MBTL1MAPK14DUSP3 | |
| SCHEMBL20149412 | 0.97 | KDM4E (0.38) | KDM4EATML3MBTL1MAPK14DUSP3 | |
| SCHEMBL26052782 | 0.96 | KDM4E (0.37) | KDM4EATML3MBTL1MAPK14DUSP3 | |
| SCHEMBL26052766 | 0.96 | KDM4E (0.37) | KDM4EATML3MBTL1MAPK14DUSP3 | |
| SCHEMBL24531856 | 0.95 | L3MBTL1 (0.39) | KDM4EATML3MBTL1MAPK14DUSP3 | |
| SCHEMBL24531798 | 0.93 | MAPK14 (0.34) | KDM4EATML3MBTL1MAPK14DUSP3 | |
| SCHEMBL24531796 | 0.93 | MAPK14 (0.34) | KDM4EATML3MBTL1MAPK14DUSP3 | |
| SCHEMBL26052539 | 0.93 | ATM (0.39) | KDM4EATML3MBTL1 | |
| SCHEMBL20149404 | 0.92 | KDM4E (0.41) | KDM4EATML3MBTL1MAPK14DUSP3 | |
| SCHEMBL16521271 | 0.92 | ATM (0.38) | KDM4EATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230363190-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20230363190-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| US-20230276704-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20230276704-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL & MATERIAL CO., LTD. (JP) | 2023-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230276704-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT, AND ORGANIC ELECTROLUMINESCENT ELEMENT | ETV6, IKZF2, EML4 | KDM4E 380/4885ATM 4641/4885L3MBTL1 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.